Salem reports profitable quarter, but loss for the full year
Salem Media Group reported a mixed bag of financial results for the fourth quarter and the full year of 2020 when it released its quarterly earnings report on March 4. The conservative media group recently moved its corporate headquarters from Camarillo to Irving, Texas, though it kept some operations in Camarillo. In 2020, Salem cut Read More →
Amgen to buy cancer treatment biotech firm for $1.9B
Thousand Oaks-based Amgen, one of the biggest biotech companies in the world, will get bigger with the $1.9 billion acquisition of Five Prime Therapeutics, a clinical-stage biotech company developing stomach cancer therapies. Amgen announced the acquisition March 4 and the deal is expected to close by the end of the second quarter of 2021. Under Read More →
Procore IPO back on track with new SEC filing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
SEC alleges pump-and-dump fraud at Airborne Wireless in Simi Valley
The U.S. Securities and Exchange Commission filed suit on March 2 against Simi Valley-based Airborne Wireless Network and seven of its shareholders and executives, accusing them of orchestrating a $45 million pump-and-dump stock fraud scheme. The lawsuit was filed in federal court in New York. The defendants are Kalistratos Kabilafkas, Timoleon Kabilafkas, Panagiotis Bolovis, Eric Read More →
AppFolio posts loss in fourth quarter
AppFolio, a Goleta-based property management software company, failed to meet analysts’ expectations with a net loss in the fourth quarter of 2020. Analysts tracked by Zacks Equity Research had predicted earnings per share of 13 cents, similar to AppFolio’s performance in the fourth quarter of 2019. Instead, the company suffered a net loss of $513,000 Read More →
MannKind stock dips on report of 2020 losses, but company touts fourth quarter comeback
MannKind Corp. struggled during 2020, but impressive financial results from its final quarter could be a sign of good things to come for the Westlake Village biotech company. MannKind, which develops drugs and treatments for those suffering from diabetes and pulmonary arterial hypertension, reported a net loss of $57.2 million in fiscal year 2020, up Read More →
Inogen announces net loss, predicts better 2021
Goleta-based Inogen reported declines in both revenue and net income due to the COVID-19 pandemic on Feb. 24, when the maker of portable oxygen concentrators released its financial results for the fourth quarter and full year of 2020. Total revenue for the fourth quarter was $74 million, a decline of 6.3% from the same quarter Read More →
